These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interleukin-1-beta, tumour necrosis factor-alpha, islet-cell antibody, and insulin secretion in children with thalassemia major on long-term blood transfusion. el Nawawy A, Soliman AT, el Azzouni O, Abbassy AA, Massoud MN, Marzouk S, Ibrahim F, Helal L. J Trop Pediatr; 1996 Dec; 42(6):362-4. PubMed ID: 9009565 [Abstract] [Full Text] [Related]
4. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping. Khalifa AS, Salem M, Mounir E, El-Tawil MM, El-Sawy M, Abd Al-Aziz MM. Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007 [Abstract] [Full Text] [Related]
5. Study of A- and B-cell function in beta-thalassemia major. Maioli M, Pacifico A, Frulio T, Longinotti M. Acta Diabetol Lat; 1983 Sep; 20(2):143-52. PubMed ID: 6349202 [Abstract] [Full Text] [Related]
7. Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data. Soliman AT, El Banna N, Abdel Fattah M, ElZalabani MM, Ansari BM. Metabolism; 1998 May; 47(5):541-8. PubMed ID: 9591744 [Abstract] [Full Text] [Related]
8. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major. Suvarna J, Ingle H, Deshmukh CT. Indian Pediatr; 2006 May; 43(5):393-400. PubMed ID: 16735760 [Abstract] [Full Text] [Related]
9. Pulmonary functions in Egyptian children with transfusion-dependent β-thalassemia. Abd El Hakeem AA, Mousa SMO, AbdelFattah MT, AbdelAziz AO, Abd El Azeim SS. Transfus Med; 2019 Feb; 29(1):55-60. PubMed ID: 30779248 [Abstract] [Full Text] [Related]
14. The effect of 3 years of recombinant growth hormone therapy on glucose metabolism in short Chinese children with beta-thalassemia major. Kwan EY, Tam SC, Cheung PT, Low LC. J Pediatr Endocrinol Metab; 2000 May; 13(5):545-52. PubMed ID: 10803873 [Abstract] [Full Text] [Related]
15. Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload. Zuppinger K, Molinari B, Hirt A, Imbach P, Gugler E, Tönz O, Zurbrügg RP. Helv Paediatr Acta; 1979 May; 34(3):197-207. PubMed ID: 500381 [Abstract] [Full Text] [Related]
16. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age. Hokken-Koelega AC, van Pareren Y, Sas T, Arends N. Horm Res; 2003 May; 60 Suppl 3():113-4. PubMed ID: 14671407 [Abstract] [Full Text] [Related]
17. Abnormal glucose tolerance in transfusion-dependent beta-thalassemic patients. Chern JP, Lin KH, Lu MY, Lin DT, Lin KS, Chen JD, Fu CC. Diabetes Care; 2001 May; 24(5):850-4. PubMed ID: 11347742 [Abstract] [Full Text] [Related]
18. Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients. Dehshal MH, Hooghooghi AH, Kebryaeezadeh A, Kheirabadi M, Kazemi S, Nasseh A, Shariftabrizi A, Pasalar P. Med Sci Monit; 2007 May; 13(5):CR235-9. PubMed ID: 17476196 [Abstract] [Full Text] [Related]
19. Pancreatic iron and glucose dysregulation in thalassemia major. Noetzli LJ, Mittelman SD, Watanabe RM, Coates TD, Wood JC. Am J Hematol; 2012 Feb; 87(2):155-60. PubMed ID: 22120775 [Abstract] [Full Text] [Related]
20. Growth and endocrine function in thalassemia major in childhood and adolescence. Delvecchio M, Cavallo L. J Endocrinol Invest; 2010 Jan; 33(1):61-8. PubMed ID: 20203539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]